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Abstract
A novel disinfectant studied using an EPA protocol demonstrated sustained antimicrobial activity (ie, 3–5 log10 reduction) in 5 minutes after
24 hours for Staphylococcus aureus, vancomycin-resistant Enterococcus, Candida auris, carbapenem-resistant Escherichia coli and antibiotic-
susceptible E. coli, and Enterobacter spp. Only ∼2 log10 reduction occurred with carbapenem-resistant Enterobacter spp and K. pneumoniae,
and antibiotic-susceptible K. pneumoniae.
(Received 14 May 2019; accepted 24 August 2019)
Environmental contamination plays an important role in the
transmission of several key healthcare-associated pathogens,
including methicillin-resistant Staphylococcus aureus (MRSA),
vancomycin-resistant Enterococcus (VRE), Clostridioides difficile,
and Acinetobacter. Ample evidence supporting the role of the
contaminated surface environment in the transmission of health-
care pathogens has been published: surfaces are frequently conta-
minated; pathogens survive for days (eg, vegetative bacteria) to
months (ie,C. difficile spores); contact with surfaces results in hand
and/or glove contamination; disinfection reduces surface and hand
contamination via touch and healthcare-associated infections;
rooms are inadequately cleaned and disinfected; patients admitted
to a room previously occupied by a patient colonized or infected
with a pathogen (eg, MRSA, VRE, or C. difficile) have an increased
likelihood of developing colonization or infection with that patho-
gen, which can be reduced by improved terminal disinfection
(eg, ultraviolet irradiation [UV]).1,2 However, a limitation of “no
touch” technologies, such as UV, is that they can only be used
for terminal room disinfection because they require removal of
all persons from the room. In addition, microbial contamination
of environmental surfaces and noncritical patient-care items
occurs continuously via patients, visitors, and staff. The intent
of routine (eg, daily) disinfection is to make surfaces and equip-
ment hygienically clean (not sterile), that is, free of pathogens in
sufficient numbers to prevent human disease.2,3 If an antimicrobial
residue remains on a disinfected surface and it persists on the
surface for 24 hours, it could guard against recontamination with
healthcare pathogens for 24 hours. In this study, we evaluated a novel
disinfectant that is registered by the Environmental Protection
Agency (EPA) to kill microbes on surfaces for at least 24 hours.
Methods
We investigated the continuously active disinfectant (CAD)
against healthcare pathogens using an EPA “Protocol for
Residual Self-Sanitizing Activity of Dried Chemical Residuals on
Hard, Non-Porous Surfaces.”4 The method simulates contact
and touches by incorporating “wear” of the test surface as well
as reinoculations of the test and control surfaces over 24 hours.
The test surfaces were inoculated with 105 test organisms (9 test
microbes, see Table 1), treated with the novel disinfectant, allowed
to dry, and then abraded using a standardized abrasion machine
under multiple alternating wet and dry wiping conditions (6 dry
cycles, 6 wet cycles, total 12 cycles [2 passes per cycle = 24 passes])
interspersed with 6 reinoculations with 103 colony-forming units
(CFU) of the test pathogen. The protocol requires a Gardco
Washability and Wear tester (Gardner, Pompano Beach, FL) to
perform the repeat abrasion portion of the test. After 24 hours,
the surface was reinoculated (106 CFU) a final time, and the ability
of the disinfectant to kill >99.9% of the 9 test microbes within
5 minutes was measured on 3 test surfaces: glass, formica, and
stainless steel. The neutralizer used in the test was 1.5% lecithin
and 5% Tween 80 (w/v) in sterile distilled water.
The novel disinfectant is EPA registered as Firebird F130
(Microban Products, Huntersville, NC) and marketed by
Professional Disposables International (Woodcliff Lake, NJ). It
has a 24-hour residual disinfectant claim and contains (w/w):
0.276% alkyl dimethyl benzyl ammonium chloride (50%C14,
40%C12, 10%C16); 0.104% didecyl dimethyl ammonium chloride;
0.207% octyl decyl dimethyl ammonium chloride; 0.104% dioctyl
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dimethyl ammonium chloride; 68.61% ethanol, as well as propri-
etary agents designed to increase longevity on the surface.5
Results
The novel disinfectant demonstrated a 3–5 log10 reduction in
5 minutes when testing S. aureus, VRE, C. auris, carbapenem-
resistant E. coli and antibiotic-sensitive strains of E. coli, and
Enterobacter spp (Table 1). The disinfectant demonstrated lower
reductions of carbapenem-resistant isolates of Enterobacter spp
and K. pneumoniae, and of antibiotic-sensitive K. pneumoniae
(∼2 log10 reduction in 5 minutes). When the novel disinfectant
was compared to 3 other commonly used disinfectants using the
same methodology with S. aureus, the mean log10 reductions were
as follows: 4.4 for novel disinfectant; 0.9 for quaternary ammonium
compound with alcohol; 0.2 for improved hydrogen peroxide; and
0.1 for chlorine.
Discussion
After cleaning and disinfection, surfaces can rapidly become
recontaminated.6 Thus, hands or gloves of healthcare providers
can become colonized or contaminated by touching contaminated
environmental surfaces and patient-care equipment. Then, via inad-
equate handhygiene or inappropriate glove use, healthcare providers
can transfer healthcare pathogens to patients. Because routine
cleaning of room surfaces by environmental services staff is fre-
quently inadequate,2 continuous room decontamination methods
would fulfill an unmet need for cleaning and disinfection. The intent
of this technology is to make surfaces hygienically clean (not sterile),
that is, free of pathogens in sufficient numbers to prevent human
disease. Technologies that could achieve and maintain low levels
of microbial contamination include visible light disinfection (eg,
high-intensity narrow-spectrum light), low concentration hydrogen
peroxide, CAD, and self-disinfection surfaces (eg, copper).2 These
technologies highlight the potential to interrupt transmission from
contaminated surfaces and equipment7 by pathogen elimination
from surfaces via healthcare provider hands and suboptimal
compliance with hand hygiene or inappropriate glove use. These
technologies are under active investigation to evaluate clinical
efficacy, but to date, only copper has been assessed for the ability
to reduce HAIs.
Our findings, which demonstrate the 3–5 log10 reductions of
epidemiologically important pathogens in 5 minutes over 24 hours
using a new CAD, are promising. The reason for a ∼2-log10 reduc-
tion (99% reduction) with carbapenem-resistant Enterobacter and
Klebsiella and sensitive Klebsiella pneumoniae in our study is
unclear. Another investigator found a 4 log10 reduction for these
pathogens (personal communication, C Donskey), and most sur-
faces have<100 CFU/Rodac (25 cm2) in the clinical environment.3
Importantly, the novel disinfectant achieved significant sustained
antimicrobial activity in 5 minutes against most pathogens after 24
hours of “wear” and reinoculations. The results of this comparative
evaluation demonstrate both no residual efficacy for the chlorine
or improved hydrogen peroxide and nonsubstantial residual anti-
microbial efficacy for the quaternary ammonium compound.
If the microbial load on surfaces is pathogen free or if patho-
gens are substantially reduced, the treated surface will not act as
reservoir for pathogens and, thus, will not be linked to disease
transmission. Thus, CAD5,8,9 (and other continuous room decon-
tamination technologies) may reduce or eliminate the problem of
recontamination and minimize the role of contaminated envi-
ronmental surfaces and equipment in transmission of healthcare
pathogens.
These data are preliminary, and further studies are needed to
determine whether the use of this disinfectant in a clinical environ-
ment reduces both microbial contamination and, ultimately,
healthcare-associated infections. This study also has several poten-
tial limitations. Only 3 surfaces (ie, glass, formica, and stainless
steel) were tested, and some surfaces (eg, bed rails) may undergo
more touches than the number used for testing in this study. A
pilot study with this CAD demonstrated superior reduction of
microbial load over 24 hours compared to a dilutable quaternary
ammonium compound or a disinfectant with ethanol and a
quaternary ammonium.5 Other considerations include frequency
of cleaning, effect of other disinfectants used on healthcare surfa-
ces, and possible development of resistance by microbes to the
CAD chemistry. The latter issue has been reviewed, and to date,
no evidence has shown that using recommended antiseptics and
disinfectants for >40 years selects for germicide-resistant or anti-
biotic-resistant organisms.10 In regard to the frequency of use, we
argue that the use of a CAD should not alter the frequency of clean-
ing and disinfection because one purpose of routine cleaning and
disinfection is to remove dirt and debris in addition to reducing
microbial contamination. The CAD can be removed from the sur-
face by chlorine, accelerated hydrogen peroxide, and a detergent.
A limitation of this technology is that it requires the application of
the product to the surface to work, so thoroughness of application
is essential.
Continued research and evaluation of the clinical value of
continuous room decontamination (including CAD) are warranted
as ameans of reducing or eliminating environmental contamination
in the transmission of healthcare-associated pathogens and decrease
healthcare-associated infections.
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A Staphylococcus aureusa 4.4 (3.9–5.0)
B S. aureus (formica) 4.1 (3.8–4.4)
C S. aureus (stainless steel) 5.5 (5.2–5.9)
D Vancomycin-resistant Enterococcus ≥4.5
E Escherichia coli 4.8 (4.6–5.0)
F Enterobacter spp 4.1 (3.5–4.6)
G Candida auris ≥5.0
H Klebsiella pneumoniae 1.5 (1.4–1.6)
I CRE E. coli 3.0 (2.6–3.4)
J CRE Enterobacter 2.0 (1.6–2.4)
K CRE K. pneumoniae 2.1 (1.8–2.4)
Note. CI, confidence interval; CRE, carbapenem-resistant Enterobacteriaceae.
aTest surface was glass.
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